Healthcare deal value rises 340 per cent in April 2026: GlobalData
Sun Pharma-Organon, Eli Lilly-Kelonia and Gilead-Tubulis among the major deals reported during the month
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Alembic Pharma gets USFDA nod for Methotrexate Injection USP, 50 mg/2 mL multi-dose vials and 1g/40…
Methotrexate Injection is a folate analog metabolic inhibitor indicated for neoplastic diseases
Pharma firms accelerate regional capacity building to secure GLP-1 supply and mitigate geopolitical…
The shift reflects intensifying demand for metabolic therapies and growing logistics risk, signaling a structural move toward…
The GLP-1 revolution
A new class of drugs is reshaping global health,but India’s generics wave could change who benefits. Dr Rajpushpa Labh,Consultant…
Lupin completes acquisition of VISUfarma
The integration of VISUfarma has expanded Lupin’s ophthalmology portfolio to over 60 branded products spanning dry eye, glaucoma,…
Glenmark to manage end-to-end commercialisation and distribution for RYALTRIS in US
RYALTRIS is Glenmark’s first innovative product introduced into the US market
Biopharma gets a boost in Budget 2026 with ₹10,000-crore outlay
Biopharma Shakti programme to boost domestic manufacturing of biologics and biosimilars. The Budget also announces customs duty…
Odisha’s pharma pitch
The recently held Odisha Pharma Summit 2025, the state’s first dedicated summit focused on pharmaceuticals, medical devices, and…
Natco to launch generic of Risdiplam for SMA patients
The company said it will launch the product immediately, with MRP of ₹15,900
Jubilant HollisterStier launches high-speed isolator based line at Spokane facility in US
This $132 million investment brings an additional 50 per cent capacity at its Spokane manufacturing facility
Deal value increased by 320 per cent in September 2025, compared to September 2024
Three major deals contributed 79.7 per cent of the total deal value during September 2025
Novo Nordisk to launch Ozempic in India, sets stage for GLP-1 market expansion
With semaglutide patents set to expire in 2026, Indian drugmakers are preparing to enter the market with generics. This…
Trump imposes 100 per cent tariff on patented drugs; impact on India to be limited
Industry experts weigh in on the latest tariff move. They highlight limited near-term disruption but caution about long-term risks…
Vidal Health and SII collaborate on HPV vaccine access
Digital health programme on Vidal Health’s platform will offer an end-to-end, convenient and cashless experience, making HPV…
Merck appoints Kai Beckmann as Chair of Executive Board and CEO
He will succeed Belén Garijo, and take charge from May 1, 2026
Lupin gets tentative US FDA nod for Bictegravir, Emtricitabine, and Tenofovir Alafenamide tablets
They are indicated for the treatment of human immunodeficiency virus infection in adults and pediatric patients weighing at least…
FDA’s curb on overseas cell processing to hit smaller cell and gene therapy companies:…
Regulators haven’t specified how many trials are affected, though therapies like CAR-T, which sometimes use overseas manufacturing…
Alembic Pharma gets EIR for its API – I & API – II facility located at Panelav
USFDA had carried out the inspection between May 26 – May 31, 2025
Shree Ramkrishna Exports Group launches Kriam Pharma
Kriam Pharma will focus on categories such as anti-diabetic, cardiac care, gastrointestinal, pain management, dermatology,…
AstraZeneca launches Eculizumab in India
It is now the first anti-complement therapy authorised in India for the treatment of for atypical Haemolytic Uremic Syndrome(aHUS)…